alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, RobinRaina, certify that:

 

1. I havereviewed this quarterly report on Form 10-Q of Ebix, Inc.;

 

2. Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

 

3. Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

 

4. Theregistrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

(a) Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

 

(b) Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

 

(c) Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

 

5. Theregistrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):

 

(a) Allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

 

(b) Any fraud,whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.

 

 
| Date:  | May 15, 2006 | /s/ Robin Raina         |   |
|--------|--------------|-------------------------|--------|
|   |         | Robin Raina             |
|   |         | Chief Executive Officer |

 

----
**EXHIBIT
      32.1**




**CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**




In
      connection with the Quarterly Report of Central Wireless, Inc. (the “Company”)
      on Form 10-QSB for the quarter ended June 30, 2005 as filed with the Securities
      and Exchange Commission on the date hereof (the “Report”), the undersigned, in
      the capacities and on the dates indicated below, hereby certifies pursuant
      to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that to his knowledge:




1.
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




2.
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operation of the Company.




Date: January
              19, 2007
            By:
            /s/ *Kenneth
              W. Brand*Kenneth
                W. Brand
              Chief
                Executive Officer




A
      signed
      original of this written statement required by Section 906, or other document
      authentications, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to Central Wireless, Inc. and will be retained
      by Central Wireless, Inc. and furnished to the Securities and Exchange
      Commission or its staff upon request.
### UNIVERSIT Y o f

f WipilUNIVERS I 

# UFlFLOR

Offic e of Universit y Rclnliun s 

### niJ^NTO r 2'U)||j;0 H I hil l i'CMh. x II3IS 7 (-uiincsvillr , ll.32(iil-3I.S 7 3r>2-«.l6-3l2' l \\\ \ Aiigiisl23 , 201 0 Alol ml.c y Associat e Directo r Smal l Coinmuiiil y Ai r

Servic e Dcvciopmcri t

Progriii n (SCASI)P ) iilolin.lev(S!Uot.Eo^ ' He : Smal l Communit y Ai r Semc e Developmen t

Gran t
Dea r Ms
. Alohn , Th e Universit y ofriorid a(UP ) I'lill y support s th e Gaincsville-Alaehu aCount y Airport Aulhorily' s reques t lo r n Smal l Communit y Ai r Servic e Dcvelopinen l gran t l o hel p suppor t

th e ne w Amcriei ml:agl e Airline s servic e betwee n Gainesvill e Jinc l Miami aiu l Ih

u existing , loca l ai r

carriers , Delt aAi r

Line s an dU S Airways
. Wit hmore than 51,00 0 students , Dorid ai s on e o f th e fiv e larges t

universitie s i

n th e nation
. A majo r rescitre huniversit y an damon g th e nation' s mus t aciulemicall y divers e publi c universities , Ul ' ha s alon g histor y orcstablislic dprogram s in internationa l e<lucation , rcscnre han dservice
. Convenienc e an dtim e i s n to p priorit y lo r man y oTou r

employees , bot hpersonall y an dprofessionally
. Ai r servic e l o America n Airlines " Miam i hu b wil l hav e asigniTicant impac t o n productivity , efficiency , an dth e qualit y o f lif e forU T faculty , sialT , students , an dfamilies
. Th e lac k o f ai r servic e t o SouthTloridann d adequat e connectin g servic e t o internationa l destination s ha s force dthos e conductin g busines s wit hUl

- t o commut e t o an dfro mothe r airpoii s o r

mak e th e exhaustin g 5 + horn ' tri p t o Miam i b y automobile
. Moi' c than 9,00 0 student s enrolle doriginat e fromMiami-Dad e an dBrowar dcounties
. Additionally , American' s extensiv e internationa l rout e structur e iron i Miami wil l provid e ne w trave l option s for oui ' internationa l student s a s wel l a s faculty an< l stafl*
. Du e l o th e critica l importanc e o f qualit y ai r

servic e fo

r ou r region , w e or e committe dt o stipporlin g American' s ne w servic e wn A continue dimprovemen t i n ai r service
. Tficreforc , w e ar c allocatin g $15,00 0 t o hel p America n Airline s establis hIt s ne w rout e betwee n GN V an dMIA
. 0\ \behal f

o f th e Universit y ofrionda' s 35,00 0 employee s an dthos e wh o conduc t busines s wit

hUl' , I urg e yo u l o procee dwithapprovin g th e Airpor t Authority' s reques t

for agran t t o assis t withmarketin g cITorl s for th e nex t tw o years . If

yo u hav e an y question s abou t Ul

- o r ou r trave l needs , pleas e don' t hesitat e l o contac t me . Sincerely , 

# Q l ^ CtMi/nny ^
Jan e Adam s
Th e Fott}i(1nlioufo r

Th e Gato r

Nalh n A n liqii.i l Oji)<orlititii ylii.>tiliit]i)i i Pag e 5 4
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1790 Uroporphyrin test system. ( a ) *Identification.* A uroporphyrin test system is a device intended to measure uroporphyrin in urine. Measurements obtained by this device are used in the diagnosis and treatment of porphyrias (primarily inherited diseases associated with disturbed porphyrin metabolism), lead poisoning, and other diseases characterized by alterations in the heme pathway.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2308, Jan. 14, 2000]
Interim Status Standards Applicability 49 

### F'R 46095 November 21, 1984 

# • FEDERAL RmU!REMENT 

### RCRA REVISICN C:-lECKLIST 10 RCRA CITE STATE AUTHORITY STATV7E 

### I REGCLATION IF'**DIF'F'ERE~** fROM**F'EDE~~** 

### REOOIREXE!\1T , 

### EXPLAIN PART 265 - UITERIM SfANr:ARDS F'OR**(fl~T£RS** AND OPERATORS OF' TSDF'S SUBPART A - 

### GENERAL 

### PURPOSE, SCOPE AND APPLICABILITY 

# •

• purpose persons to wham regs apply

" 265.1(a) 265.1(b) ! 1173-303-400( 1)

# ~73-303-400(1 ;&(Z)(a)

xovenbe r 21/ 1984 - ?ar;e 1 of 1
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.5915 Manual emergency ventilator. ( a ) *Identification.* A manual emergency ventilator is a device, usually incorporating a bag and valve, intended to provide emergency respiratory support by means of a face mask or a tube inserted into a patient's airway.
( b ) *Classification.* Class II (performance standards).
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7754 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7754

To amend the Colorado Wilderness Act of 1993 to add certain land to the 
            Sarvis Creek Wilderness, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 20, 2024

  Mr. Neguse introduced the following bill; which was referred to the 
                     Committee on Natural Resources

_______________________________________________________________________

                                 A BILL

 
To amend the Colorado Wilderness Act of 1993 to add certain land to the 
            Sarvis Creek Wilderness, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sarvis Creek Wilderness Completion 
Act''.

SEC. 2. DEFINITIONS.

    In this Act:
            (1) Sarvis creek wilderness addition.--The term ``Sarvis 
        Creek Wilderness Addition'' means the land added to the Sarvis 
        Wilderness by the amendment made by section 3(a).
            (2) Secretary.--The term ``Secretary'' means the Secretary 
        of Agriculture.

SEC. 3. DESIGNATION OF SARVIS CREEK WILDERNESS ADDITION.

    (a) Designation.--Section 2(a)(11) of the Colorado Wilderness Act 
of 1993 (16 U.S.C. 1132 note; Public Law 103-77) is amended by striking 
``1993,'' and inserting ``1993, and certain land within the Routt 
National Forest that comprises approximately 6,817 acres, as generally 
depicted as `Sarvis Creek Wilderness Addition Proposal' on the map 
entitled `Sarvis Creek Wilderness Addition Proposal' and dated February 
26, 2024,''.
    (b) Applicable Law.--The reference in section 4(d)(4) of the 
Wilderness Act (16 U.S.C. 1133(d)(4)) to the effective date of that Act 
shall be considered to be a reference to the date of enactment of this 
Act for purposes of administering the Sarvis Creek Wilderness Addition.

SEC. 4. ADMINISTRATIVE PROVISIONS.

    (a) Tribal Rights and Use.--
            (1) Treaty rights.--Nothing in this Act affects the treaty 
        rights of any Indian Tribe.
            (2) Traditional tribal uses.--The Secretary may, in 
        accordance with applicable law, permit Indian Tribes access to, 
        and use of, the Sarvis Creek Wilderness Addition for 
        traditional, religious, and cultural purposes.
    (b) Fire, Insects, and Diseases.--In accordance with section 
4(d)(1) of the Wilderness Act (16 U.S.C. 1133(d)(1)), the Secretary may 
carry out any activity in the Sarvis Creek Wilderness Addition that the 
Secretary determines to be necessary for the control of fire, insects, 
and diseases, subject to such terms and conditions as the Secretary 
determines to be appropriate.
                                 <all>
```
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-13-00696-CV

IN THE INTEREST OF J.R.R., et al., Children

From the 225th Judicial District Court, Bexar County, Texas

Trial Court No. 2012-PA-02174

Honorable Charles E. Montemayor, Judge Presiding

BEFORE CHIEF JUSTICE STONE, JUSTICE MARTINEZ, AND JUSTICE ALVAREZ

In accordance with this court’s opinion of this date, the motion to withdraw filed by 

appellant’s attorney is GRANTED, and the trial court’s order is AFFIRMED. It is ORDERED 

that no costs shall be assessed against appellant in relation to this appeal because she qualifies as 

an indigent under TEX. R. APP. P. 20.

SIGNED February 5, 2014.

_____________________________

Catherine Stone, Chief Justice
# C_2015138EN.01004801.xml

| 27.4.2015 | EN | Official Journal of the European Union | C 138/48 |
| --- | --- | --- | --- |

27.4.2015

EN

Official Journal of the European Union

C 138/48

---

Judgment of the General Court of 6 March 2015 — Novomatic v OHIM — Berentzen Mally Marketing plus Services (BLACK JACK TM)

(Case T-257/14) (1)

1

((Community trade mark - Opposition Proceedings - Application for Community figurative mark BLACK JACK TM - Earlier Community word and figurative marks BLACK TRACK - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

(2015/C 138/62)

Language of the case: German

Parties

Parties

Applicant: Novomatic AG (Gumpoldskirchen, Austria) (represented by: W. Mosing, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented initially by A. Pohlmann, and subsequently by S. Hanne, acting as Agents)

Defendant:

Other party to the proceedings before the Board of Appeal of OHIM: Berentzen Mally Marketing plus Services GmbH (Meerbusch, Germany)

Other party to the proceedings before the Board of Appeal of OHIM:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 18 February 2014 (Case R 329/2012-4), relating to opposition proceedings between Berentzen Mally Marketing plus Services GmbH and Novomatic AG.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Annuls the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 18 February 2014 (Case R 329/2012-4); |
| --- | --- |

1.

Annuls the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 18 February 2014 (Case R 329/2012-4);

| 2. | Orders OHIM to pay the costs, including those incurred in the proceedings before the Board of Appeal. |
| --- | --- |

2.

Orders OHIM to pay the costs, including those incurred in the proceedings before the Board of Appeal.

---

(1)  OJ C 194, 24.6.2014.

1

---
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3660 Phenobarbital test system. ( a ) *Identification.* A phenobarbitol test system is a device intended to measure phenobarbital, an antiepileptic and sedative-hypnotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of phenobarbital use or overdose and in monitoring levels of phenobarbital to ensure appropriate therapy.
( b ) *Classification.* Class II.
- USGS Home
- Contact						   USGS
- Search USGS
-     - USGS Publications Warehouse
  - Contact
  - Explore recent publications     by USGS							   Authors
  - Browse all of Pubs Warehouse     by							   Publication type and year
  - FAQS
  - Web     Service Documentation
  - Other     Resources
  - Descriptions of US     Geological Survey Report							   Series 
- USGS Publications   Warehouse
- Explore    - Explore recent publications     by USGS							   Authors
  - Browse all of Pubs Warehouse     by							   Publication type and year 
- Documentation    - FAQS
  - Web     Service Documentation
  - Other     Resources
  - Descriptions of US     Geological Survey Report							   Series 
- Contact
Search:					    				    			                                             The Upper Cretaceous floras of Alaska, with a description of the plant-bearing bedsProfessional Paper 159- By:
- Arthur   Hollick and G.C. Martin                         
TweetLinks- More information:  National Geologic Map Database Index Page                                  (html)
- Document:  Document                                   (56136 pdf)                             
- Plate:  Plate 87                                   (1433 pdf)                             
- Download citation as:   RIS
AbstractAdditional publication details- Publication type:
- Report
- Publication Subtype:
- USGS Numbered Series
- Title:
- The Upper Cretaceous floras of Alaska, with a description of the   plant-bearing beds
- Series title:
- Professional Paper
- Series number:
- 159
- Edition:
- -
- Year Published:
- 1930
- Language:
- ENGLISH
- Description:
- 123 p.

Part or all of this report is presented in Portable Document Format (PDF). For best results viewing and printing PDF documents, it is recommended that you download the documents to your computer and open them with Adobe Reader. PDF documents opened from your browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information about viewing, downloading, and printing report files can be found here.

AccessibilityFOIAPrivacyPolicies and					   Notices

U.S. Department of the					   Interior |				    U.S. Geological Survey				   URL: http://pubs.er.usgs.gov/publication/pp159                     				   Page Contact Information: Pubs Warehouse Contact				   Page				   Page Last Modified: February 02, 2012 00:10:19
###### Editorial Note on Part 316

#### Editorial Note:

Nomenclature changes to part 316 appear at 69 FR 13717, Mar. 24, 2004.

#### § 316.40 Treatment use of a designated orphan drug.

Prospective investigators seeking to obtain treatment use of designated orphan drugs may do so as provided in subpart I of this chapter.

[74 FR 40945, Aug. 13, 2009]
§ 520.1696a Penicillin G powder. ( a ) *Specifications.* Each gram of powder contains penicillin G potassium equivalent to 1.54 million units of penicillin G.
( b ) *Sponsors.* See Nos. 016592, 042791, 054771, 061133, and 076475 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.510 of this chapter.
( d ) *Conditions of use in turkeys* — ( 1 ) *Amount.* 1,500,000 units per gallon drinking water for 5 days.
( 2 ) *Indications for use.* Treatment of erysipelas caused by *Erysipelothrix rhusiopathiae.*
( 3 ) *Limitations.* Discontinue treatment at least 1 day prior to slaughter. Not for use in turkeys producing eggs for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[57 FR 37326, Aug. 18, 1992, as amended at 59 FR 42493, Aug. 18, 1994; 60 FR 26359, May 17, 1995; 62 FR 55160, Oct. 23, 1997; 65 FR 10705, Feb. 29, 2000; 66 FR 14073, Mar. 9, 2001; 68 FR 4914, Jan. 31, 2003; 68 FR 26204, May 15, 2003; 69 FR 9946, Mar. 3, 2004; 69 FR 41428, July 9, 2004; 77 FR 20988, Apr. 9, 2012; 78 FR 28825, May 20, 2014; 81 FR 22523, Apr. 18, 2016; 81 FR 36789, June 8, 2016; 81 FR 94990, Dec. 27, 2016; 84 FR 8973, Mar. 13, 2019. Redesignated at 85 FR 18119, Apr. 1, 2020, as amended at 86 FR 57997, Oct. 20, 2021]
§ 507.47 Validation. ( a ) You must validate that the preventive controls identified and implemented in accordance with § 507.34 are adequate to control the hazard as appropriate to the nature of the preventive control and its role in the facility's food safety system.
( b ) The validation of the preventive controls: ( 1 ) Must be performed (or overseen) by a preventive controls qualified individual: ( i ) ( A ) Prior to implementation of the food safety plan; or
( B ) When necessary to demonstrate the control measures can be implemented as designed: ( 1 ) Within 90 calendar days after production of the applicable animal food first begins; or
( 2 ) Within a reasonable timeframe, provided that the preventive controls qualified individual prepares (or oversees the preparation of) a written justification for a timeframe that exceeds 90 calendar days after production of the applicable animal food first begins;
( ii ) Whenever a change to a control measure or combination of control measures could impact whether the control measure or combination of control measures, when properly implemented, will effectively control the hazards; and
( iii ) Whenever a reanalysis of the food safety plan reveals the need to do so.
( 2 ) Must include obtaining and evaluating scientific and technical evidence (or, when such evidence is not available or is inadequate, conducting studies) to determine whether the preventive controls, when properly implemented, will effectively control the hazards.
( c ) You do not need to validate: ( 1 ) The sanitation controls in § 507.34(c)(2);
( 2 ) The recall plan in § 507.38;
( 3 ) The supply-chain program in subpart E of this part; and
( 4 ) Other preventive controls, if the preventive controls qualified individual prepares (or oversees the preparation of) a written justification that validation is not applicable based on factors such as the nature of the hazard, and the nature of the preventive control and its role in the facility's food safety system.
[80 FR 56337, Sept. 17, 2015, as amended at 81 FR 3718, Jan. 22, 2016]
# C_2015065EN.01002001.xml

| 23.2.2015 | EN | Official Journal of the European Union | C 65/20 |
| --- | --- | --- | --- |

23.2.2015

EN

Official Journal of the European Union

C 65/20

---

Request for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 19 November 2014 — Sparkasse Allgäu v Finanzamt Kempten

(Case C-522/14)

(2015/C 065/29)

Language of the case: German

Referring court

Referring court

Bundesfinanzhof

Parties to the main proceedings

Parties to the main proceedings

Applicant: Sparkasse Allgäu

Applicant:

Defendant: Finanzamt Kempten

Defendant:

Question referred

Question referred

Does the freedom of establishment (Article 49 of the Treaty on the Functioning of the European Union, ex Article 43 [of the Treaty establishing] the European Communities) preclude a provision in a Member State under which a credit institution established in its national territory must, on the death of a domestic testator, also notify the tax office responsible for the administration of inheritance tax in the national territory of those of the testator’s assets which are held or managed in a dependent branch of the credit institution in another Member State, where there is no similar notification obligation in the other Member State and credit institutions in that State are subject to banking secrecy any breach of which constitutes a criminal offence?

---
§ 556.168 Coumaphos. ( a ) [Reserved]
( b ) *Tolerances.* The tolerances for coumaphos (measured as coumaphos and its oxygen analog, O,O-diethyl O-3- chloro-4-methyl-2-oxo-2 H-1- benzopyran-7-yl phosphate) are: ( 1 ) *Chickens.* ( i ) Edible tissues (excluding eggs): 1 ppm.
( ii ) Eggs: 0.1 ppm.
( 2 ) [Reserved]
( c ) *Related conditions of use.* See § 558.185 of this chapter.
[86 FR 14821, Mar. 19, 2021]
#### § 82.1708 D&C Yellow No. 8.

The color additive D&C Yellow No. 8 shall conform in identity and specifications to the requirements of § 74.1707(a)(1) and (b) of this chapter. D&C Yellow No. 8 is restricted to use in externally applied drugs and cosmetics.